Generate a tailored SOP for Dr. Rita Nanda. Improve your application with a focused, well-structured draft.
Rita Nanda, MD, is an Associate Professor in the Biological Sciences Division at the University of Chicago, focusing on clinical aspects of breast cancer. Her research involves the examination of treatment modalities, specifically CDK4/6 inhibition in advanced hormone receptor-positive and HER2-negative breast cancer. Dr. Nanda has actively contributed to numerous studies published in prestigious journals, discussing treatment efficacy, toxicity, and the survival outcomes of breast cancer patients, including those who are childhood cancer survivors. Her work also highlights disparities in immunotherapy use among different breast cancer subtypes. Furthermore, she has explored biomarkers related to immune responses in early-stage breast cancer, enhancing the understanding of hormone receptor-positive and triple-negative breast cancers. With a dedicated research profile, Dr. Nanda strives to improve clinical outcomes for breast cancer patients through innovative therapeutic strategies and comprehensive patient care.
Department of Philosophy